Atopic Dermatitis Market is Predicted to Grow at a Remarkable CAGR by 2032, Analyzes DelveInsight | Key Companies – Pfizer, AbbVie, Daiichi Sankyo, Novartis, and PurGenesis

 Breaking News
  • No posts were found

Atopic Dermatitis Market is Predicted to Grow at a Remarkable CAGR by 2032, Analyzes DelveInsight | Key Companies – Pfizer, AbbVie, Daiichi Sankyo, Novartis, and PurGenesis

June 20
20:23 2022
Atopic Dermatitis Market is Predicted to Grow at a Remarkable CAGR by 2032, Analyzes DelveInsight | Key Companies - Pfizer, AbbVie, Daiichi Sankyo, Novartis, and PurGenesis
Delveinsight Business Research LLP
DelveInsight’s “Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Atopic Dermatitis Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Atopic Dermatitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Atopic Dermatitis Market

Atopic Dermatitis: An Overview

Atopic dermatitis (AD), also known as atopic eczema, is a type of inflammation of the skin (dermatitis). It results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which often thickens over time. While the condition may occur at any age, it typically starts in childhood with changing severity over the years. In children under one year of age much of the body may be affected. 

According to the National Eczema Association 2020, Itch is the most burdensome symptom of AD, followed by skin redness and dryness. A recent study of adults with moderate to severe AD found that 70.5% reported severe, unbearable itch in the past two weeks, 85.8% reported daily itch, and 62.8% reported itching at least 12 hours per day.

Atopic Dermatitis Market Key Facts

  • As per the National Eczema Association, 2019, Atopic dermatitis (AD) is the most common type of eczema. In fact, more than 18 million American adults have atopic dermatitis which often appears as a red, itchy rash normally on the cheeks, arms, and legs.

  • According to the DelveInsight estimates, a large number of people are suffering from mild Atopic Dermatitis. In the United States, the prevalent population of Atopic Dermatitis was found to be 19,460,600+ in 2017. 

  • As per DelveInsight estimates, a higher prevalent population of uncontrolled Atopic Dermatitis is observed in the United States as compared to EU5 countries and Japan.

  • According to DelveInsight’s findings, females are affected more as compared to males, in the case of Atopic Dermatitis.

Atopic Dermatitis Market

Atopic Dermatitis market size is expected to increase during the forecast period owing to the rise in the number of Prevalent cases of Atopic Dermatitis patients in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Atopic Dermatitis market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Atopic Dermatitis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Atopic Dermatitis Epidemiology

The epidemiology section covers insights about the historical and current Atopic Dermatitis patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Atopic Dermatitis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Atopic Dermatitis market or expected to get launched in the market during the study period. The analysis covers Atopic Dermatitis market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Atopic Dermatitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Get the PDF Sample of the Report:-

Atopic Dermatitis Therapeutics Analysis

The Atopic Dermatitis market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world, and the expected launch of emerging therapies.

Some of the key Companies in the Atopic Dermatitis Market include:

  • Pfizer

  • AbbVie

  • Daiichi Sankyo

  • Novartis Pharmaceuticals

  • PurGenesis Technologies

And many others.

Atopic Dermatitis Therapies Covered in the Report Include:

  • Abrocitinib

  • ZPL389

  • DS-2741a

  • Upadacitinib

  • PUR0110

And many more. 

Get More Detailed Insights into the Emerging Therapies & Key Companies:-

Table of Content

1. Key Insights

2. Executive Summary 

3. Atopic Dermatitis Competitive Intelligence Analysis

4. Atopic Dermatitis Market Overview at a Glance

5. Atopic Dermatitis Disease Background and Overview

6. Atopic Dermatitis Patient Journey

7. Atopic Dermatitis Epidemiology and Patient Population

8. Atopic Dermatitis Treatment Algorithm, Current Treatment, and Medical Practices

9. Atopic Dermatitis Unmet Needs

10. Key Endpoints of Atopic Dermatitis Treatment

11. Atopic Dermatitis Marketed Products

12. Atopic Dermatitis Emerging Therapies

13. Atopic Dermatitis Seven Major Market Analysis

14. Attribute Analysis

15. Atopic Dermatitis Market Outlook (7 major markets)

16. Atopic Dermatitis Access and Reimbursement Overview

17. KOL Views on the Atopic Dermatitis Market.

18. Atopic Dermatitis Market Drivers

19. Atopic Dermatitis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:-

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Nasolabial Fold Market

“Nasolabial Fold Market” research report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Nasolabial Fold market trends in 7MM.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Related Articles